Strativest CapitalSTRATIVEST RESEARCH
Independent research · Est. October 2026
← All X-Rays
Stock X-Ray · Materials · S&P 500 Full Coverage — Phase 1

Air Products (APD)

X-Ray dated Oct 28, 2026 · Share price as of Oct 28, 2026 intraday, when the valuation snapshot was captured · Financials from SEC filings (EDGAR) · Valuation multiples from a labelled secondary source
The verdict — valuation label: UNDERVALUED

Forward P/E is 21.55x against a peer median of 24.68x, a ratio of 0.87x — below the fair range — with trailing P/E not available (shown as n/a) and PEG 2.22. Latest-quarter revenue grew 4.6% year over year (PRIMARY, EDGAR); revenue is still growing, not shrinking, and the cluster median is positive, so the value-trap check does not move the label to fairly priced. Delivered demand check: the chemicals & industrial gases group's median growth was 9.3% year over year — demand steady, though this company is growing more slowly than that pace.

21.6×
Forward P/E — price vs next year’s expected earnings (secondary source)
24.7×
Peer median forward P/E — closest comparable companies
—
Trailing P/E — price vs the last twelve months of earnings
5.4×
Price / sales

What would change this label: Move to FAIRLY PRICED if the forward P/E rises to about 22.2x or above (0.90x the peer median) at unchanged estimates, entering the fair band, or if revenue growth falls below 0% year over year for two quarters. Move to OVERVALUED if the forward P/E rises above about 28.4x (1.15x the peer median) without revenue growth rising above the cluster median of 9.3%.

In simple words

Air Products sells industrial gases that factories and refiners use every day. Its shares trade at about 22 times expected earnings, a little below similar companies at about 25 times, while its sales grew about 5%. On the peer comparison the shares look undervalued, though the growth is slow for the price.

Words we use, in plain English: P/E ratio — the share price divided by earnings per share; how many dollars you pay for one dollar of yearly profit. Forward P/E — the same, using next year’s expected earnings. Free cash flow — cash a company has left after running the business and buying equipment. TTM — the last twelve months. Drawdown — the worst fall from a peak to the low after it.
The share price vs the market — six years
Air Products (APD)S&P 500 (SPY)
601031461892322021202220232024202520262020-09-012026-10-27

Both lines start at 100 on 2020-09-01. Over the full window Air Products returned +1.45% and the S&P 500 +118.28% (price returns; dividends not reinvested). Worst peak-to-trough fall for Air Products: -33.8% (2022-12-13 to 2024-02-07). Source: Nasdaq official daily history.

What the label rests on

Forward P/E is 21.55x against a peer median of 24.68x, a ratio of 0.87x — below the fair range — with trailing P/E not available (shown as n/a) and PEG 2.22. Latest-quarter revenue grew 4.6% year over year (PRIMARY, EDGAR); revenue is still growing, not shrinking, and the cluster median is positive, so the value-trap check does not move the label to fairly priced. Delivered demand check: the chemicals & industrial gases group's median growth was 9.3% year over year — demand steady, though this company is growing more slowly than that pace. The company’s forward P/E is 21.6× against a peer median of 24.7×. Its own history: UNVERIFIED — no sourced range available. Sector demand read: Delivered demand check: the chemicals & industrial gases group's median latest-quarter revenue growth was 9.3% year over year (SEC filings) — demand steady. This company grew 4.6%, more slowly than the group median. Latest-quarter sales growth was +4.6% versus a year earlier (SEC filings).

CompanyPrice (Oct 28, 2026)Forward P/ETrailing P/E
Air Products (APD)$307.4521.6×—
SHW$320.1224.7×29.5×
ECL$292.0932.7×39.7×
PPG$119.6814.0×17.1×
DOW$34.0916.3×—
IFF$90.5426.2×83.7×
Peer median24.7×

Multiples: stockanalysis.com (SECONDARY, S&P Global data), fetched Oct 28, 2026. Peer set chosen by sector; the median is the middle value of the set. The label and its numbers were recorded in the programme’s label registry on Oct 28, 2026 and will be scored at 6 and 12 months.

Sales, profit and cash

Sales and profit each quarter
SalesNet income (profit)
$0B$1B$3B$4BSep 2020Sep 2021Sep 2022Sep 2023Sep 2024Sep 2025Jun 2026

This company does not report a gross-profit line in its SEC facts (normal for banks, payment networks and some health insurers), so profit is shown as net income instead — gross margin is marked UNVERIFIED-absent rather than estimated.

Cash left over each quarter (free cash flow)
PositiveNegative
$-2B$0B$2BSep 2020Sep 2021Sep 2022Sep 2023Sep 2024Sep 2025Jun 2026

Free cash flow = cash from operations minus spending on plant and equipment, both from the company’s SEC cash-flow statement. Gaps are quarters where that spending line is not separately tagged in the filings — shown as gaps, never estimated.

QuarterSalesGross marginNet incomeEPS (GAAP, diluted)Free cash flow
Q/E Jun 2026
2026-06-30
$3.2B—$-1.4B-6.47$310M
Q/E Mar 2026
2026-03-31
$3.2B—$710M3.19$-4M
Q/E Dec 2025
2025-12-31
$3.1B—$678M3.04$-350M
Q/E Sep 2025
2025-09-30
$3.2B—$5M——
Q/E Jun 2025
2025-06-30
$3.0B—$714M3.20$-640M
Q/E Mar 2025
2025-03-31
$2.9B—$-1.7B-7.77$-1.6B
Q/E Dec 2024
2024-12-31
$2.9B—$617M2.77$-1.3B
Q/E Sep 2024
2024-09-30
$3.2B—$1.9B——
Q/E Jun 2024
2024-06-30
$3.0B—$697M3.13$-345M
Q/E Mar 2024
2024-03-31
$2.9B—$572M2.57$-868M
Q/E Dec 2023
2023-12-31
$3.0B—$609M2.73$-819M
Q/E Sep 2023
2023-09-30
$3.2B—$693M——

The last twelve reported quarters. Full 24-quarter history sits in the data pack behind this page. A dash means the figure is not tagged as a standalone quarter in the company’s SEC facts (the usual case is the fourth quarter, which many companies only report inside the full-year filing) — it is missing, not zero.

Earnings: getting better or worse?

Each box is one quarter’s earnings per share (EPS). Green means EPS was higher than the same quarter a year earlier; red means lower; a dash means the figure is not tagged in the filings.

Sep 2022
—
Dec 2022
2.57
Mar 2023
1.97
Jun 2023
2.67
Sep 2023
—
Dec 2023
2.73
Mar 2024
2.57
Jun 2024
3.13
Sep 2024
—
Dec 2024
2.77
Mar 2025
-7.77
Jun 2025
3.20
Sep 2025
—
Dec 2025
3.04
Mar 2026
3.19
Jun 2026
-6.47

Basis: GAAP diluted EPS from SEC company facts, compared with the same quarter a year earlier.

Key facts

ItemValue
Company (legal name in filings)Air Products & Chemicals, Inc.
Chief executiveEduardo Menezes (source: https://www.airproducts.com/company/news-center/2026/10/1026-air-products-appoints-kurt-lefevere-and-francesco-maione-as-group-presidents)
SectorMaterials — Industrial Gases — sells industrial gases such as hydrogen, oxygen and nitrogen to factories, refiners and hospitals
Share price (Oct 28, 2026)$307.45
Market value (market cap)$68.4B — share price times shares outstanding of 222,685,530 (SEC filings; SEC EDGAR dei EntityCommonStockSharesOutstanding (latest))
Sales, last twelve months$12.6B
Net income, last twelve months$-47M
Free cash flow, last twelve months—
Latest reported quarterQ/E Jun 2026 (of 24 quarters in the data pack)
Six-year price return vs S&P 500+1.45% vs +118.28%
Worst peak-to-trough fall-33.8% (2022-12-13 to 2024-02-07)

What we could not verify

  • Gross profit / gross margin: not tagged as a standalone line in this company's EDGAR company facts (common for banks, payment networks and some healthcare payers) — shown as UNVERIFIED-absent; the page charts revenue and net income instead.
  • TTM GAAP diluted EPS could not be summed from company facts because at least one of the last four quarters (typically Q4) has no standalone tagged EPS; trailing P/E is therefore taken from the labelled secondary source in valuation_label.md.
  • Free cash flow is absent for one or more quarters: either the filer does not separately tag PP&E purchases in its EDGAR cash-flow facts (common for banks), or — for a successor registrant's newest quarter — the cash-flow lines are year-to-date without the prior-quarter rung needed to difference them. Affected quarters are null in the data, never estimated.
  • Own-history P/E range not yet compiled for this company in the Phase 1 batch run; the label rests on peer-median, growth and PEG evidence.
  • Trailing P/E was shown as n/a on the statistics page, so no trailing P/E evidence is available for this label.
  • Guidance record (each quarter scored against the guidance the company gave the quarter before) is not yet compiled for this company — it is a Phase 2 layer. The earnings strip below therefore uses reported EPS versus a year earlier, which is fully sourced from filings.

The IT factor — the most exciting thing the market is overlooking — is not assessed on an X-Ray page. It belongs to the Deep Dive (Phase 2), where it gets the evidence standard it needs. Leadership-era scoring (the six years split by chief executive) is likewise a Phase 2 layer; this page names the current chief executive only, from a sourced profile.

Sources

  • SEC EDGAR submissions — Filing index; company legal name. https://data.sec.gov/submissions/CIK0000002969.json
  • SEC EDGAR company facts — Quarterly financial spine: revenue, gross profit, net income, GAAP diluted EPS, operating cash flow, PP&E capex, buybacks, dividends, diluted shares. https://data.sec.gov/api/xbrl/companyfacts/CIK0000002969.json
  • Nasdaq official daily history — Daily closes for the company; SPY (assetclass=etf) saved as raw/nasdaq_spy_raw.json over identical dates. https://api.nasdaq.com/api/quote/APD/historical?assetclass=stocks
  • Valuation multiples and peer figures — stockanalysis.com (SECONDARY, S&P Global data), fetched Oct 28, 2026; see valuation_label.md in the data pack.

Conventions: earliest-filed value per period, as first reported; cash-flow years-to-date differenced quarter by quarter; EPS never differenced; free cash flow = operating cash flow minus plant-and-equipment spending. This page is a dated snapshot — updates are new versions, never silent edits.

← All X-RaysS&P 500 Full Coverage — Phase 1 · Oct 28, 2026